Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADCY1 | Q08828 | 6/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.35 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.35 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | ADCY8 | P40145 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24724145 | 0.82 | KMT2A (0.46) | ADCY1EPHX2MAPTMEN1KMT2A | |
| SCHEMBL6431313 | 0.82 | CA1 (0.38) | ADCY1EPHX2MAPTMEN1KMT2A | |
| SCHEMBL16278092 | 0.78 | HTR4 (0.47) | — | |
| SCHEMBL408394 | 0.75 | NPC1 (0.42) | ADCY1EPHX2MAPTMEN1KMT2A | |
| SCHEMBL439761 | 0.75 | NPC1 (0.42) | ADCY1EPHX2MAPTMEN1KMT2A | |
| SCHEMBL17040253 | 0.74 | PTPN1 (0.50) | PTPN1 | |
| SCHEMBL20305423 | 0.73 | CA1 (0.43) | ADCY1MAPTMEN1KMT2ACA1 | |
| SCHEMBL442998 | 0.73 | PKM (0.41) | ADCY1EPHX2PTPN1MEN1KMT2A | |
| SCHEMBL408407 | 0.73 | PKM (0.41) | ADCY1EPHX2PTPN1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL11596232 | 0.71 | PTPN1 (0.48) | PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3623372-B1 | PYRROLO AND PYRAZOLOPYRIMIDINES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS | VALO HEALTH INC (US) | 2026-02-04 | — | — | EP | disclosed |
| EP-3623372-A1 | PYRROLO AND PYRAZOLOPYRIMIDINES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS | Forma Therapeutics, Inc. (US) | 2020-03-18 | — | — | EP | disclosed |
| EP-3240791-B1 | PYRROLO AND PYRAZOLOPYRIMIDINES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS | FORMA THERAPEUTICS INC (US) | 2019-11-06 | — | — | EP | disclosed |